Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000392
UniProt IDQ96GV9
Primary gene name(s)C5orf30
Synonym gene name(s)unknown
Protein nameUNC119-binding protein C5orf30
Protein functionProbably plays a role in trafficking of proteins via its interaction with UNC119 and UNC119B cargo adapters: may help the release of UNC119 and UNC119B cargo or the recycling of UNC119 and UNC119B, PubMed:22085962. May play a role in ciliary membrane localization via its interaction with UNC119B and protein transport into photoreceptor cells, PubMed:22085962. {ECO:0000269|PubMed:22085962}.
Subcellular locationCytoplasm {ECO:0000269|PubMed:22085962}. Cell projection, cilium {ECO:0000269|PubMed:22085962}. Note=Localizes to the transition zone and proximal cilium in addition to being found throughout the cytoplasm. {ECO:0000269|PubMed:22085962}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q96GV9
Gene Ontology
(Biological Process)
Complete annatation
cilium assembly [GO:0060271];
negative regulation of cytokine production involved in inflammatory response [GO:1900016];
negative regulation of fibroblast migration [GO:0010764];
protein transport [GO:0015031]
Gene Ontology
(Molecular Function)
Complete annatation
Gene Ontology
(Cellular Component)
Complete annatation
ciliary transition zone [GO:0035869];
cytoplasm [GO:0005737]
Protein-protein interaction124702
Phylogenetic treeQ96GV9
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD31.636052111243562.10988447313376e-061.52299706796322e-05
AZA vs. DISU0.116736700622070.6579685070800390.960426582104957
AZA vs. IL70.4921347646268580.01631767983500650.421477444934655
AZA vs. SAHA-0.0400714513865780.8755642790958310.972026888688393
DISU vs. CD3-1.530803340016377.37980400962179e-050.000434883368416884
DISU vs. IL70.3661737821393320.1618463623085080.521177174865965
DISU vs. SAHA-0.1560459803002290.6044685440687980.875198907451327
DMSO vs. AZA-0.04676158046761240.8001800875881681
DMSO vs. CD3-1.693637641915284.97725782366842e-073.7717499554107e-06
DMSO vs. DISU-0.165558165026370.5152388645730320.91278621053738
DMSO vs. IL70.5459235629344210.004513628339173570.13528560326202
DMSO vs. SAHA-0.0008559760881924930.9972351211430580.999549535705062
HIV vs. Mock in Activation-0.1329083813228240.8316584303712020.999983755607037
HIV vs. Mock in Latency0.1269583906727510.4876076534350490.999834320637052
IL7 vs. CD3-1.133212008200480.000630942620393760.00286451750517926
SAHA vs. CD3-1.701109347933554.60823486814199e-063.17540463936442e-05
SAHA vs. IL7-0.5368002957388750.03416858251909120.142241704748075
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.484943 0.0449168
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

not found

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found